| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Emmaus Life Sciences, Inc. (EMMA) has 0 insiders with recent SEC Form 4 filings, including 12 buys and 0 sells. EMMA is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Aug 9, 2017 | Pappajohn John | - | Buy | 5,000 | $3.34 | $16,683.50 | +0.9% | |
| Aug 2, 2017 | Pappajohn John | Director, 10% Owner | Buy | 5,000 | $3.65 | $18,242.00 | +0.9% | |
| Jul 25, 2017 | Pappajohn John | Director, 10% Owner | Buy | 5,000 | $4.00 | $19,996.00 | +1.0% | |
| Jul 21, 2017 | Pappajohn John | Director, 10% Owner | Buy | 10,000 | $4.25 | $42,493.00 | +1.0% | |
| Jul 18, 2017 | Pappajohn John | Director, 10% Owner | Buy | 10,000 | $4.47 | $44,694.50 | +1.0% | |
| Apr 3, 2017 | Pappajohn John | Director, 10% Owner | Buy | 9,878 | $6.46 | $63,843.49 | +2.0% | |
| Mar 20, 2017 | Rsj Investments Sicav A.S. | 10% Owner | Buy | 160,000 | $6.25 | $1,000,000.00 | +34.4% | |
| Dec 13, 2016 | Smith Robin L | Director | Buy | 5,000 | $6.00 | $30,000.00 | +5.8% | |
| Oct 20, 2016 | Pappajohn John | Director, 10% Owner | Buy | 200 | $8.50 | $1,700.00 | - | |
| Oct 17, 2016 | Pappajohn John | Director, 10% Owner | Buy | 1,000 | $8.00 | $8,000.00 | +0.3% |